← back to search

Payal Tiwari

Broad Institute ·
Area of research
Cancer Research · Oncology
Research interest
Research interests include MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, and Melanoma and MAPK Pathways.
h-index
9
citations
1,639
works
44
NIH funding
primary concept
email

Recent publications

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Cell Reports Medicine 2025cited by 9position: middledoi
Targeting TBK1 to overcome resistance to cancer immunotherapy
Nature 2023cited by 165position: middledoi
Limited inhibition of multiple nodes in a driver network blocks metastasis
eLife 2021cited by 34position: middledoi
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Nature 2019cited by 411position: middledoi
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
The Journal of Experimental Medicine 2019cited by 115position: firstdoi
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
Oncogene 2015cited by 73position: middledoi
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Cancer Discovery 2012cited by 379position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marsha Rich Rosner · University of Chicago3 papers (2019–2021)Ali E. Yesilkanal · Bristol-Myers Squibb (Germany)2 papers (2019–2021)Marcus E. Peter · Northwestern University2 papers (2012–2015)Casey Frankenberger · Rush University Medical Center2 papers (2019–2021)Anirban Mitra · Indiana University Health2 papers (2012–2015)Ernst Lengyel · Health First2 papers (2012–2015)Andrea Valdespino · The Wistar Institute1 papers (2021–2021)Galina Khramtsova · University of Chicago1 papers (2019–2019)Gary L. Johnson · University of North Carolina at Chapel Hill1 papers (2021–2021)Jason W. Locasale · North Central State College1 papers (2019–2019)Olufunmilayo I. Olopade · Chicago Department of Public Health1 papers (2019–2019)Lev Becker · MEI Pharma (United States)1 papers (2019–2019)Ariane Blank · University of Chicago1 papers (2019–2019)Long C. Nguyen · Massachusetts General Hospital1 papers (2021–2021) · 1 papers (2021–2021)Youjia Hua · Novartis (China)1 papers (2012–2012)Peter C. Hart · University of Chicago1 papers (2019–2019)Joseph Wynne · United States Food and Drug Administration1 papers (2019–2019) · 1 papers (2019–2019)Seema A. Khan · Northwestern University1 papers (2019–2019)